English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Texas House of Representatives
Patient Daily
| Dec 31, 2025
Texas House Majority leader Oliverson: 340B is a 'dumpster fire of a program'
Trending
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+
Pharmaceuticals
Patient Daily
| Jan 30, 2026
Senate gridlock delays decision on rare disease priority review voucher program
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
+
Pharmaceuticals
Patient Daily
| Jan 27, 2026
FDA extends review timelines for four priority voucher drugs
